biotechnology
Optimizing Surface Cultivation: How Process Parameters Shape Single-Cell Oil Production in Cutaneotrichosporon oleaginosus
This article explores how response surface methodology is revolutionizing the production of single-cell oils from Cutaneotrichosporon oleaginosus, highlighting the influence of temperature, pH, and dissolved oxygen on lipid yield and fatty acid composition—key factors for sustainable and scalable microbial oil…
U.S. Halts mRNA Vaccine Research Funding: Implications for Global Health
The U.S. government has canceled $500 million in funding for mRNA vaccine development, sparking concerns about the future of pandemic preparedness and advancements in biotechnology.
Sarepta Therapeutics Restructures Amid Challenges with Gene Therapy Elevidys
Sarepta Therapeutics has announced a major restructuring, laying off 36% of its workforce and shifting its research focus amid safety concerns surrounding its gene therapy Elevidys.
How AI Is Revolutionizing Protein Science with AlphaFold3
Google DeepMind’s AlphaFold3 is transforming protein science by predicting molecular shapes, paving the way for breakthroughs in medicine and climate solutions.
26 New Microbe Species Found in NASA Cleanrooms: Study
Scientists discover 26 novel microbe species thriving in NASA cleanrooms, sparking concerns over space contamination and biotechnological opportunities.
SOHM Launches AI Team to Boost Genome Editing Technology
SOHM, Inc., a pharmaceutical and biotechnology company, announced the formation of a dedicated AI team on April 7, 2025, to enhance its ABBIE genome editing system and develop innovative RNA-guided tools for advancements in gene therapy and other fields.
Apellis Pharmaceuticals Strengthens Position in Rare Disease Treatment with $709 Million Revenue in 2024
Apellis Pharmaceuticals, a global biopharmaceutical leader, has closed 2024 with robust financial results, reporting $709 million in U.S. net product revenues. This impressive performance reflects the success of SYFOVRE®, its groundbreaking treatment for geographic atrophy (GA), which generated $611 million…
Bioptimus Secures $76 Million to Unify Biology with AI, Launching Groundbreaking Foundation Model in 2025
Bioptimus, an innovative AI-driven biology company, has secured $76 million in funding, including a $41 million Series A round led by Cathay Innovation. This milestone supports the development of a groundbreaking multi-scale, multi-modal foundation model for biology, slated for release…